Latest News

by Yvonne Zacrosse. Posted on September 1, 2016

MYLAN, THE PHARMACEUTICAL company caught in a public firestorm over its surge in EpiPen list prices, has announced results of its own internal research regarding the cause of list prices rising from $164.98 in 2011 to $608.61 currently for a brand name EpiPen 2-Pak.


by Maxine Debuque, Phd. Posted on September 1, 2016

OSCAR HEALTH, THE TECH-DRIVEN venture-backed health insurance startup geared towards millennials, has announced a pivot in corporate direction, after losses of $100 million in 2015 and possibly double that in 2016. After indicating they are withdrawing from Dallas and New Jersey health insurance markets, the company signaled they are pivoting to a model deriving high download fees from their consumer friendly apps.


by Winona Woodword. Posted on September 1, 2016

FACING A READMISSIONS CRISIS, administrators at Ravendale Regional Medical Center in Northern California developed a plan to convert one of their medical-surgical units to condominiums. "It's worked out quite nicely so far," shares hospital executive Stephen Vogt.

The hospital, experiencing a rapid rise in Medicare readmissions, was already undergoing a renovation in their west med-surg wing when it dawned on Vogt that with a few tweaks, the unit could be modified to become condominiums for their chronic patients.